- 801. Eligibility
- [The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures. ( NCI )] (UMLS (NCI) C0013893) =Health Care Activity
| - 851. Embolism and thrombosis of iliac artery
- [ ] (UMLS (ICD9CM) C0155755) =Pathologic Function ;
|
- 802. Eligibility Source
- (UMLS (HL7) C1550418) =Classification =HL7 Vocabulary Version 2.5;
=Insurance Company;
Employer;
Insured presented policy;
Insured presented card;
Signed statement on file;
Verbal information;
None | - 852. Embolism and thrombosis of other specified artery
- [ ] (UMLS (ICD9CM) C0155754) =Disease or Syndrome ;
|
- 803. EligibilityActReasonCode
- [Identifies the reason or rational for why a person is eligibile for benefits under an insurance policy or progam. Examples: A person is a claimant under an automobile insurance policy are client deceased & adopted client has been given a new policy identifier. A new employee is eligible for health insurance as an employment benefit. A person meets a government program eligibility criteria for financial, age or health status. ( HL7V3.0 )] (UMLS (HL7) C1699570) =Idea or Concept ;
=ActReason;
=CoverageEligibilityReason | - 853. Embolism and thrombosis of other specified veins
- [ ] (UMLS (ICD9CM) C0155777) =Pathologic Function ;
|
- 804. Eligible
- [Insurance coverage is in effect for healthcare service(s) and/or product(s). ( HL7V3.0 )] (UMLS (HL7) C1548635) =Idea or Concept =Certification status;
ActCoverageEligibilityConfirmationCode | - 854. Embolism and thrombosis of renal vein
- [ ] (UMLS (ICD9CM) C0155776) =Pathologic Function ;
|
- 805. Eliminated
- [Taken out of, separated from, or eliminated. ( NCI )] (UMLS (NCI) C0849355) Out;
Removed;
Taken Out =Qualitative Concept | - 855. Embolism and thrombosis of thoracic aorta
- [ ] (UMLS (ICD9CM) C0155750) =Disease or Syndrome; Anatomical Abnormality
|
- 806. Elipten
- (UMLS (NCI) C0701949) =Organic Chemical; Pharmacologic Substance
| - 856. Embolism and thrombosis of unspecified site
- [obstruction of a blood vessel with thrombotic material carried by the blood stream from the site of origin to plug another vessel. ( CSP )] (UMLS (ICD9CM) C0040038) =Pathologic Function =embolism;
thrombosis =Intracranial Embolism and Thrombosis;
Embolism, Paradoxical |
- 807. ELISA
- [immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase; while either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye; many variations of the method have been developed. ( CSP )] (UMLS (HL7) C0014441) =Laboratory Procedure =immunologic assay;
ObservationMethod | - 857. Embolism and thrombosis of vena cava
- [ ] (UMLS (ICD9CM) C0155775) =Pathologic Function ;
|
- 808. ELISA, antigen capture
- [ELISA, antigen capture ( HL7V3.0 )] (UMLS (HL7) C1553127) =Laboratory Procedure =ObservationMethod;
| - 858. Embolism following abortion or ectopic and molar pregnancies
- [ ] (UMLS (ICD9CM) C0495169) =Disease or Syndrome
|
- 809. ELISA, avidin biotin peroxidase complex
- [ELISA, avidin biotin peroxidase complex ( HL7V3.0 )] (UMLS (HL7) C0201697) =Laboratory Procedure =ObservationMethod;
| - 859. embolization
- [(EM-bo-lih-ZAY-shun) The blocking of an artery by a clot or foreign material. Embolization can be done as treatment to block the flow of blood to a tumor. ( NCI )] (UMLS (NCI) C0013931) =Therapeutic or Preventive Procedure ;
|
- 810. ELISA, peroxidase-antiperoxidase
- [ELISA, peroxidase-antiperoxidase ( HL7V3.0 )] (UMLS (HL7) C0201698) =Laboratory Procedure =ObservationMethod;
| - 860. embryo
- [Early stage in the development of a plant or an animal. In vertebrate animals (have a backbone or spinal column), this stage lasts from shortly after fertilization until all major body parts appear. In particular, in humans, this stage lasts from about 2 weeks after fertilization until the end of the seventh or eighth week of pregnancy. ( NCI )] (UMLS (NCI) C0013935) =Embryonic Structure ;
|
- 811. ELISPOT
- [ ] (UMLS (CSP) C0920508) enzyme linked immunospot assay =Laboratory Procedure
| - 861. embryo cancer
- [new abnormal embryonic tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C0027654) =Neoplastic Process ;
=germ cell neoplasm;
|
- 812. ELISPOT (enzyme linked immunospot assay)
- [ ] (UMLS (CSP) C0677645) =Laboratory Procedure ;
| - 862. embryo cell
- [ ] (UMLS (CSP) C0920487) =Embryonic Structure ;
|
- 813. Eliten
- [The sodium salt of fosinopril, a phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Fosinopril sodium is an ester prodrug that is hydrolysed by esterases to its active metabolite fosinoprilat. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase of serum potassium. (NCI05) ( NCI )] (UMLS (NCI) C0733440) FOSINOPRIL SODIUM;
FOSINOPRIL SODIUM PREPARATION;
L-proline, 4-Cyclohexyl-1-[[[2-methyl-1-(1-oxopropoxy) propoxyl](4-phenylbutyl) phosphinyl]acetyl]-,Sodium Salt, trans- =Organophosphorus Compound; Pharmacologic Substance =FOSINOPRIL;
=FOSINOPRIL SODIUM 10 MG;
FOSINOPRIL SODIUM 20 MG;
FOSINOPRIL SODIUM 40 MG | - 863. embryo cell culture
- [ ] (UMLS (CSP) C0920504) embryonic cell culture =Laboratory Procedure
|
- 814. ELIXIR
- [A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI) ( NCI )] (UMLS (NCI) C0678430) =Biomedical or Dental Material =Oral Solution;
| - 864. embryo chemotherapy
- [ ] (UMLS (CSP) C0920488) =Therapeutic or Preventive Procedure ;
|
- 815. Elixophyllin
- (UMLS (NCI) C0700831) =Organic Chemical; Pharmacologic Substance
| - 865. embryo circulation
- [ ] (UMLS (CSP) C0920742) =Organ or Tissue Function ;
|
- 816. Elk Valley Rancheria, California
- (UMLS (HL7) C1554299) =Population Group =NativeEntityContiguous;
| - 866. embryo culture
- [ ] (UMLS (CSP) C0920489) =Research Activity ;
|
- 817. ELK1
- [ELK1 Protein is a member of the ELK subfamily of ETS DNA-binding transcription factors. (from OMIM 311040 and NCI) ( NCI )] (UMLS (NCI) C0209089) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 867. embryo death
- [ ] (UMLS (CSP) C0752350) =Pathologic Function ;
|
- 818. ELK1
- [This gene plays a role in transcriptional regulation and mediates DNA-binding interactions. The gene is also involved in MAP kinase signal transduction. ( NCI )] (UMLS (NCI) C0812446) ELK1 Gene;
ELK1, Member of ETS Oncogene Family Gene;
=Gene or Genome | - 868. embryo disorder
- [ ] (UMLS (CSP) C0920490) =Disease or Syndrome ;
|
- 819. ELK3
- [This gene is involved in B-cell development and immunoglobulin gene regulation. ( NCI )] (UMLS (NCI) C0812375) ELK3 Gene;
ELK3, ETS-Domain Protein (SRF Accessory Protein 2) Gene =Gene or Genome ;
| - 869. embryo drug adverse effect
- [ ] (UMLS (CSP) C0920491) =Injury or Poisoning ;
|
- 820. ELK3
- [ELK3 Protein, an ELK subfamily member of ETS-related DNA-binding transcription factors, is highly expressed at early stages of B-lymphocyte development, declining upon cell maturation. ELK3 may play a role in B-cell development and Ig gene regulation. (from OMIM 600247 and NCI) ( NCI )] (UMLS (NCI) C1321890) ELK3 Protein;
ELK3, ETS-Domain Protein;
ETS-Domain Protein;
ETS-Domain Protein ELK-3;
ETS-Related Protein;
ETS-Related Protein ERP;
ETS-Related Protein NET;
SAP-2;
SAP2 Protein;
SRF Accessory Protein 2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 870. embryo growth disorder
- [ ] (UMLS (CSP) C0920492) =Disease or Syndrome ;
|
- 821. Ellence
- (UMLS (NCI) C0701345) =Organic Chemical; Pharmacologic Substance ;
| - 871. embryo hypoxia
- [ ] (UMLS (CSP) C0920493) =Disease or Syndrome ;
|
- 822. Elliotts B Solution
- (UMLS (NCI) C0059031) =Pharmacologic Substance ;
| - 872. embryo implantation
- [embedding of a fertilized ovum (blastocyst) into the endometrium; in humans, this occurs six or seven days after fertilization. ( CSP )] (UMLS (CSP) C0029976) =Organism Function =pregnancy;
|
- 823. ellipse
- [An ellipse defined by four (column,row) pairs, the first two points specifying the endpoints of the major axis and the second two points specifying the endpoints of the minor axis. ( HL7V3.0 )] (UMLS (HL7) C1553440) =Intellectual Product =ROIOverlayShape;
| - 873. Embryo infective dose 50
- [Bioassay, Embryo Infective Dose 50 ( HL7V3.0 )] (UMLS (HL7) C1551413) =Laboratory Procedure =ObservationMethod;
|
- 824. Elliptocytosis
- (UMLS (NCI) C0427480) =Finding
| - 874. Embryo lethal dose 50
- [Bioassay, Embryo Lethal Dose 50 ( HL7V3.0 )] (UMLS (HL7) C1551414) =Laboratory Procedure =ObservationMethod;
|
- 825. ELM
- [A plant genus of the family ULMACEAE that is susceptible to Dutch elm disease which is caused by the ASCOMYCOTA fungus, Ophiostoma. ( MSH )] (UMLS (NCI) C0330531) =Plant
| - 875. embryo membrane
- [ ] (UMLS (CSP) C0920494) =Embryonic Structure ;
|
- 826. Elmiron
- (UMLS (NCI) C0600293) =Carbohydrate; Pharmacologic Substance ;
| - 876. embryo monitoring
- [ ] (UMLS (CSP) C0920495) =Diagnostic Procedure ;
|
- 827. Elobromol
- (UMLS (NCI) C0878349) =Carbohydrate; Pharmacologic Substance ;
| - 877. embryo nutrition
- [ ] (UMLS (CSP) C0920496) =Organism Attribute ;
|
- 828. elongation factor
- [ ] (UMLS (CSP) C0086206) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 878. embryo pharmacology
- [ ] (UMLS (CSP) C0920497) =Biomedical Occupation or Discipline ;
|
- 829. Elongin Binding Protein
- [A product of the von Hippel Lindau tumor suppressor gene, Elongin Binding Protein (VHL) is a general transcription elongation factor that increases the rate at which RNA polymerase II transcribes DNA by suppressing polymerase pausing. VHL is part of a complex (VCB) that includes elongin B, elongin C, and cullin-2, proteins associated with transcriptional elongation and ubiquitination. VHL directly interacts with, and inhibits, SP1. VHL inhibits expression of hypoxia-inducing VEGF and GLUT1 genes. (from OMIM 193300 and NCI) ( NCI )] (UMLS (NCI) C0299505) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 879. embryo pharmacotherapy
- [ ] (UMLS (CSP) C1328876) =Therapeutic or Preventive Procedure; ;
|
- 830. ELOXATIN
- (UMLS (NCI) C1135117) Eloxatine =Organic Chemical; Pharmacologic Substance
| - 880. embryo preservation
- [Methods for short term or long term preservation of embryos at the two cell stage or beyond. Examples: short term storage in buffered media with serum at reduced temperature or long term cryopreservation in liquid nitrogen. ( NCI )] (UMLS (CSP) C0920498) =Laboratory Procedure ;
|
- 831. Elspar
- (UMLS (NCI) C0699262) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme
| - 881. embryo protein
- [ ] (UMLS (CSP) C0920499) embryonic protein =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 832. Ely Shoshone Tribe of Nevada
- (UMLS (HL7) C1554300) =Population Group =NativeEntityContiguous;
| - 882. embryo resorption
- [ ] (UMLS (CSP) C0013937) =Organism Function ;
|
- 833. EM-652
- (UMLS (NCI) C0115717) =Organic Chemical; Pharmacologic Substance ;
| - 883. embryo surgery
- [ ] (UMLS (CSP) C0920500) =Therapeutic or Preventive Procedure
|
- 834. EM/Strontium Chloride Sr 89/VBL
- (UMLS (NCI) C0338309) =Therapeutic or Preventive Procedure ;
| - 884. embryo therapy
- [ ] (UMLS (CSP) C0920501) =Therapeutic or Preventive Procedure
|
- 835. EM/TAX
- (UMLS (NCI) C0281442) =Therapeutic or Preventive Procedure
| - 885. embryo tissue
- [ ] (UMLS (CSP) C0920502) Embryonic Tissue =Embryonic Structure
|
- 836. EM/TAX/VP-16
- (UMLS (NCI) C0677756) =Therapeutic or Preventive Procedure ;
| - 886. embryo tissue transplantation
- [ ] (UMLS (CSP) C0920700) embryonic tissue transplantation =Therapeutic or Preventive Procedure ;
|
- 837. EM/VBL
- (UMLS (NCI) C0281287) =Therapeutic or Preventive Procedure
| - 887. embryo toxicology
- [ ] (UMLS (CSP) C0920503) =Biologic Function
|
- 838. EM/VNB
- (UMLS (NCI) C0281729) =Therapeutic or Preventive Procedure
| - 888. embryo transfer
- [Refers to a step in the process of in vitro fertilization (IVF) whereby one or several embryos are removed from an embryo culture and placed into the uterus of the female with the intent to establish a pregnancy. ( NCI )] (UMLS (CSP) C0013938) =Therapeutic or Preventive Procedure ;
|
- 839. EM/VP-16
- (UMLS (NCI) C0281417) =Therapeutic or Preventive Procedure
| - 889. embryo/fetus
- [animal at any stage of development prior to birth or hatching. ( CSP )] (UMLS (CSP) C0230999) =Embryonic Structure =embryology;
life cycle =amniotic fluid;
chick embryo;
embryo/fetus culture;
embryo/fetus membrane;
|
- 840. Emaciation
- [Clinical manifestation of excessive LEANNESS usually caused by disease or a lack of nutrition (MALNUTRITION). ( MSH )] (UMLS (NCI) C0013911) =Sign or Symptom =Body Weight Changes;
=cachexia;
| - 890. embryo/fetus antigen
- [antigen demonstratable during fetal life but not normally in adults. ( CSP )] (UMLS (CSP) C0312558) =Amino Acid, Peptide, or Protein; Immunologic Factor =antigen;
=carcinoembryonal antigen |
- 841. email
- [Participation by text or diagrams transmitted over an electronic mail system. ( HL7V3.0 )] (UMLS (HL7) C1553519) =Idea or Concept =written;
| - 891. embryo/fetus cell culture
- [ ] (UMLS (CSP) C0596499) =Laboratory Procedure ;
|
- 842. EMANCIPATION DISORDER
- [ ] (UMLS (ICD9CM) C0154585) =Mental or Behavioral Dysfunction
| - 892. embryo/fetus cell/tissue
- [tissue or cells from unborn young; for culture of isolated ex vivo embryonic or fetal cells or tissues index EMBRYO/FETUS CELL CULTURE; for more specific human fetal tissue index HUMAN FETUS TISSUE. ( CSP )] (UMLS (CSP) C0920780) =Embryonic Structure = ;
embryology;
Normal Tissue;
=germ layer;
Embryonic Stem Cell;
human fetal tissue |
- 843. Embarin
- (UMLS (NCI) C1449489) Suspendol;
=Organic Chemical; Pharmacologic Substance | - 893. embryo/fetus chemotherapy
- [application of the beneficial effects of drugs to control or cure diseases or abnormal states in an embryo or a fetus. ( CSP )] (UMLS (CSP) C0596500) =Therapeutic or Preventive Procedure ;
=chemotherapy;
embryo/fetus therapy |
- 844. Embarrassment
- [An unpleasant emotional state experienced upon having an inadequacy, guilt, or socially unacceptable act or trait witnessed by or revealed to others. ( NCI )] (UMLS (NCI) C0679112) =Mental Process
| - 894. embryo/fetus culture
- [in vitro culture of whole embryos or fetuses. ( CSP )] (UMLS (CSP) C0596501) =Research Activity ;
=embryo/fetus;
tissue/cell culture |
- 845. Embden Meyerhof pathway
- [The main pathway for anaerobic degradation of carbohydrates. Starch or glycogen is hydrolyzed to glucose 1-phosphate and then through a series of intermediates, yielding two ATP molecules per glucose and producing either pyruvate (which feeds into the tricarboxylic acid cycle) or lactate. [http://cancerweb.ncl.ac.uk/] ( GO )] (UMLS (CSP) C0520922) =Molecular Function
| - 895. embryo/fetus death
- [death of the developing young before birth. ( CSP )] (UMLS (CSP) C0920760) =Pathologic Function =pregnancy loss;
|
- 846. Embedded query language query
- (UMLS (HL7) C1548027) =Idea or Concept =Message type;
| - 896. embryo/fetus disorder
- [Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. ( MSH )] (UMLS (CSP) C0015929) =Disease or Syndrome ;
=Pregnancy Complication;
congenital disorder;
Neonatal Diseases and Abnormalities;
=Alcohol affecting fetus or newborn via placenta or breast milk;
FET GROWTH RETARD WTNOS;
embryo/fetus hypoxia;
Chorioamnionitis;
erythroblastosis fetalis;
Alcohol affecting fetus or newborn via placenta or breast milk;
Fetal Anoxia;
Distress, fetal;
FET GROWTH RETARD WTNOS;
fetal macrosomia;
Meconium Aspiration |
- 847. Embolectomy
- [Surgery performed with the purpose of removing an embolus. ( NCI )] (UMLS (NCI) C0162575) =Therapeutic or Preventive Procedure ;
| - 897. embryo/fetus drug adverse effect
- [unintended, deleterious effects of otherwise licit, therapeutic, properly administered drugs on the developing embryo or fetus; includes manifestations after birth; for effects of illicit and abused drugs or environmental chemicals, see EMBRYO/FETUS TOXICOLOGY or POISONING. ( CSP )] (UMLS (CSP) C0596502) =Injury or Poisoning ;
=drug adverse effect;
embryo/fetus pharmacology |
- 848. emboliform nucleus
- [ ] (UMLS (CSP) C0175488) =Body Part, Organ, or Organ Component
| - 898. embryo/fetus hypoxia
- [oxygen deficiency in the embryo or fetus. ( CSP )] (UMLS (CSP) C0935448) =Disease or Syndrome ;
=embryo/fetus disorder;
|
- 849. embolism
- [blocking of a blood vessel by a blood clot or foreign matter that has been transported from a distant site by the blood stream. ( CSP )] (UMLS (NCI) C0013922) =Pathologic Function =Embolism and Thrombosis;
blood vessel occlusion =Aeroembolism;
Embolism and thrombosis of unspecified site;
Aeroembolism;
AMNIOTIC EMBOLISM-UNSPEC;
Embolism, Fat;
BIRIKA EMBOLIA;
Embolism and thrombosis of unspecified site;
Atheroembolism | - 899. embryo/fetus membrane
- [thin layers of tissue which surround the embryo or fetus and provide for its nutrition, respiration, excretion and protection; they form from the egg but are not part of the embryo itself; include the yolk sac, allantois, amnion, and chorion. ( CSP )] (UMLS (CSP) C0935447) =Embryonic Structure ;
=embryo/fetus;
=amnion;
trophoblast;
vitelline membrane;
vitelline sac;
CAM |
- 850. Embolism and thrombosis of arteries of the extremities
- [ ] (UMLS (ICD9CM) C0340579) =Disease or Syndrome ;
| - 900. embryo/fetus monitoring
- [physiologic or biochemical monitoring of the fetus; usually done during birth and may be performed in conjunction with the monitoring of uterine activity; may also be performed prenatally as when the mother is undergoing surgery. ( CSP )] (UMLS (CSP) C0920770) =Diagnostic Procedure =antepartum diagnosis;
patient monitoring device |
home
